Literature DB >> 30713796

Genomic and transcriptional Profiling of tumor infiltrated CD8+ T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma.

Zhenli Li1,2, Geng Chen1,2,3, Zhixiong Cai1,2,3, Xiuqing Dong1,2, Liman Qiu1,2, Haipo Xu1,2, Yongyi Zeng1,4,2, Xiaolong Liu1,2, Jingfeng Liu1,4,2.   

Abstract

As key players in HCC antitumor response, the functions of tumor infiltrated CD8+ T cells are significantly affected by surrounding microenvironment. A detailed profiling of their genomic and transcriptional changes could provide valuable insights for both future immunotherapy development and prognosis evaluation. We performed whole exome and transcriptome sequencing on tumor infiltrated CD8+ T cells and CD8+ T cells isolated from other tissue origins (peritumor tissues and corresponding PBMCs) in eight treatment-naive HCC patients. The results demonstrated that transcriptional changes, rather than genomic alterations were the main contributors to the functional alterations of CD8+ T cells in the process of tumor progression. The origins of CD8+ T cells defined their transcriptional landscape, while the tumor infiltrated CD8+ T cells shared more similarity with peritumor-derived CD8+ T cells compared with those CD8+ T cells in blood. In addition, tumor infiltrated CD8+ T cells also showed larger transcriptional heterogeneity among individuals, which was modulated by clinical features such as HBV levels, preoperative anti-viral treatment and the degree of T cell infiltration. We also identified multiple inter-connected pathways involved in the activation and exhaustion of tumor infiltrated CD8+ T cells, among which IL-12 mediated pathway could dynamically reflect the functional status of CD8+ TILs and activation of this pathway indicated a better prognosis. Our results presented an overview picture of CD8+ TILs' genomic and transcriptional landscape and features, as well as how the functional status of CD8+ TILs correlated with patients' clinical course.

Entities:  

Keywords:  CD8+ T cells; Hepatocellular carcinoma (HCC); IL-12 signaling pathway; transcriptome analysis; tumor infiltrated lymphocytes (TILs)

Year:  2018        PMID: 30713796      PMCID: PMC6343808          DOI: 10.1080/2162402X.2018.1538436

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  51 in total

1.  IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells.

Authors:  Robin Parihar; Julie Dierksheide; Yan Hu; William E Carson
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells.

Authors:  Chance John Luckey; Deepta Bhattacharya; Ananda W Goldrath; Irving L Weissman; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

3.  The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication.

Authors:  Yuji Sobao; Hiroko Tomiyama; Kazuhiro Sugi; Michiyo Tokunaga; Takamasa Ueno; Satoru Saito; Shigetoshi Fujiyama; Manabu Morimoto; Katsuaki Tanaka; Masafumi Takiguchi
Journal:  J Hepatol       Date:  2002-01       Impact factor: 25.083

Review 4.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

5.  IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells.

Authors:  T Sareneva; I Julkunen; S Matikainen
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

6.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.

Authors:  Rachel M McLoughlin; Brendan J Jenkins; Dianne Grail; Anwen S Williams; Ceri A Fielding; Clare R Parker; Matthias Ernst; Nicholas Topley; Simon A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

7.  Diagnosis of multiple cancer types by shrunken centroids of gene expression.

Authors:  Robert Tibshirani; Trevor Hastie; Balasubramanian Narasimhan; Gilbert Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

8.  Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis.

Authors:  A Thakur; M Xue; F Stapleton; A R Lloyd; D Wakefield; M D P Willcox
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 9.  The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease.

Authors:  Michael P Keane; Robert M Strieter
Journal:  Respir Res       Date:  2001-10-15

10.  Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.

Authors:  George J M Webster; Stephanie Reignat; David Brown; Graham S Ogg; Louise Jones; Suranjith L Seneviratne; Roger Williams; Geoffrey Dusheiko; Antonio Bertoletti
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  5 in total

1.  Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma.

Authors:  Guangyi Jiang; Liang Shi; Xueyong Zheng; Xinjie Zhang; Ke Wu; Boqiang Liu; Peijian Yan; Xiao Liang; Tunan Yu; Yifan Wang; Xiujun Cai
Journal:  Aging (Albany NY)       Date:  2020-06-24       Impact factor: 5.682

Review 2.  Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.

Authors:  Weili Jia; Tianchen Zhang; Qianyun Yao; Jianhui Li; Ye Nie; Xinjun Lei; Zhenzhen Mao; Yanfang Wang; Wen Shi; Wenjie Song
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 3.  Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.

Authors:  Bin Li; Cong Yan; Jiamin Zhu; Xiaobing Chen; Qihan Fu; Hangyu Zhang; Zhou Tong; Lulu Liu; Yi Zheng; Peng Zhao; Weiqin Jiang; Weijia Fang
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

Review 4.  Calreticulin and cancer.

Authors:  Jitka Fucikova; Radek Spisek; Guido Kroemer; Lorenzo Galluzzi
Journal:  Cell Res       Date:  2020-07-30       Impact factor: 25.617

5.  Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.

Authors:  Yinghui Hou; Guizhi Zhang
Journal:  Diagn Pathol       Date:  2021-07-04       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.